BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Injectable Drug Delivery is an industry focused on two overarc
 hing topics the development of the device and the interaction between dru
 g product and device. SAE’s 2024 Injectable Drug Delivery conference brin
 gs together a complete big pharma speaker line-up providing technical upd
 ates on the relationship between drug product formulation and the device 
 primary packaging\, with considerations for formulation strategies\, extr
 actables and leachables and toxicological testing of injectable devices.\
 n\nThis conference brings case studies from senior big pharma representat
 ives providing an opportunity to discuss formulation considerations in de
 pth for parenteral packaging\, this is the perfect opportunity to benchma
 rk your drug delivery programme and optimise the development of your inje
 ctable portfolio.\n\nThe 2024 conference differentiates itself to other i
 njectables conferences through focused technical presentations on device 
 primary packaging and material selection for the advanced drug products o
 f the future with case studies from Sanofi\, Roche and Bayer. Additionall
 y\, focused presentations on user driven platform development and the rol
 e this has had at AstraZeneca and Novo Nordisk to enhance their parentera
 l delivery portfolio.These technical sessions bring together leading scie
 ntists working directly in the field to allow for an intimate and direct 
 networking opportunity. This focus on technical\, in-depth presentations 
 allows for a tailored audience of device developers compared to wide and 
 varied audience of competitors conferences.\n\nWhat will you gain?\n\n- E
 valuate how devices can be co-developed alongside drug products to foster
  a collaborative approach to improve biocompatibility and effective toxic
 ological testing\n\n- Expand on design strategies for injectable delivery
  of advanced modalities\, including cell and gene therapies\, large molec
 ule delivery and sub-zero device requirements\n\n- Learn through focused 
 presentations tailored to a technical device development and primary pack
 aging audience\, exploring vial material and primary component selection\
 , silicone layer thickness studies and standardisation of primary contain
 er formats\n\n- Benefit from spotlight sessions focusing on sustainable d
 evice materials\, offering comprehensive perspectives on material develop
 ment and selection through to disposal\n\n- Learn how major device develo
 pers are streamlining product development and CMC practices for effective
  compliance throughout and post-NDA/MAA approval\n\n&nbsp\;\n\nTime: 8:30
  AM - 5:00 PM\n
DTEND:20240509T170000
DTSTAMP:20260512T232944Z
DTSTART:20240508T083000
LOCATION:Hilton London Kensington\, 179-199\, Holland Park Avenue\, London
 \, England\, W11 4UL\,
SEQUENCE:0
SUMMARY:Injectable Drug Delivery is an industry focused on two overarching
  topics the development of the device and the interaction between drug pr
 oduct an...
UID:3d44058b-bda7-444c-99c0-3e96f31ef6fe
END:VEVENT
END:VCALENDAR
